News for hackers. Stuff that matters.
Re:Despite concerns, FDA approves new opioid 10x more powerf... by esotericn on Friday November 02, 2018 @04:46PM (#18366593)
This article seems pretty low on detail. Almost all of it seems to be talking about, well, not the drug in question.

What, exactly, does "10x more powerful" mean?

Potency? Presumably it'd then be prescribed in lower doses?

Re:Despite concerns, FDA approves new opioid 10x more powerf... by DevX101 on Friday November 02, 2018 @05:03PM (#18366731)
Here is an image comparing the lethal dose of heroin vs fentanyl.

https://www.statnews.com/wp-content/uploads/2016/09/Heroin-F...

Re:Despite concerns, FDA approves new opioid 10x more powerf... by robbyking on Friday November 02, 2018 @05:15PM (#18366842)
Drugs don't look fun anymore.
Re:Despite concerns, FDA approves new opioid 10x more powerf... by twoheadedboy on Friday November 02, 2018 @05:20PM (#18366881)
That is a ludicrously small amount, holy moly.
Re:Despite concerns, FDA approves new opioid 10x more powerf... by bootlooped on Friday November 02, 2018 @05:38PM (#18366981)
Wait till you see the lethal dose of one more synthetic opioid:

http://mediad.publicbroadcasting.net/p/wosu2/files/styles/me...

Re:Despite concerns, FDA approves new opioid 10x more powerf... by vilhelm_s on Friday November 02, 2018 @11:36PM (#18368540)
That picture is misleading. Although the pain relief effect of carfentalin is ~35 times higher than fentanyl, the lethal dose of both drugs is about the same. So carfentanil is actually safer, in the sense that it has a higher therapeutic index.

https://twitter.com/davidjuurlink/status/859227636400349184?...

Re:Despite concerns, FDA approves new opioid 10x more powerf... by jcranmer on Friday November 02, 2018 @05:42PM (#18367007)
Botox is lethal at ~1ng per kg of body weight. It takes 20,000 times that amount of the compound in question to kill you. (These are both using LD50 numbers).
Re:Despite concerns, FDA approves new opioid 10x more powerf... by Pharmakon on Friday November 02, 2018 @06:32PM (#18367268)
Botox is a refined form of one of the most lethal substances to humans, it is a poison, and most of all it’s not a recreational drug of abuse commonly smuggled around the world. You also can’t absorb it through your skin like fentanyl and carfentanil. Brief contact with botulinum toxin won’t kill you, but brief contact with a rice-grain sized particle of carfentanil can and will.
Re:Despite concerns, FDA approves new opioid 10x more powerf... by 13of40 on Friday November 02, 2018 @04:50PM (#18366617)
One hundredth the size of a grain of salt vs. one tenth for fentanyl? Imagine if a piece of dust from that blew into your eye.
Re:Despite concerns, FDA approves new opioid 10x more powerf... by maverick2007 on Friday November 02, 2018 @04:58PM (#18366695)
This is probably a stupid question but is it possible for this or for any drug to be absorbed and take effect via the eye? Or does it have to get into the circulatory/digestive system to take effect?
Re:Despite concerns, FDA approves new opioid 10x more powerf... by mveety on Friday November 02, 2018 @05:15PM (#18366840)
No question is stupid! For fentanyl at least that can totally happen. On of the common ways to administer it is via a transdermal patch. It’s one of the major selling points of fentanyl and why people that need ridiculous amounts of opioids because of burns or cancer like it.
Re:Despite concerns, FDA approves new opioid 10x more powerf... by ddingus on Friday November 02, 2018 @07:13PM (#18367496)
>No question is stupid!

Hear, hear!

Especially in this context. I have a modest understanding of just a couple of these compounds. And that comes by way of chronic pain people in my life.

Over time, doing the work to better undestand these things has paid off. They, at times, get contradictory or just bad advice, or see something that makes them worry, or think they are in danger somehow.

It can be hard to get clarity, and know a change is thearaputic vs compliance related, for example.

Anyway, I just liked that you said that and followed up with super easy to understand information.

Re:Despite concerns, FDA approves new opioid 10x more powerf... by Balgair on Friday November 02, 2018 @06:10PM (#18367158)
Side note: This reminds me of RedEye from Cowboy Bebop: http://cowboybebop.wikia.com/wiki/Red_Eye
Re:Despite concerns, FDA approves new opioid 10x more powerf... by sb8244 on Friday November 02, 2018 @05:15PM (#18366838)
One of the classic LSD stereotypes is eye drop. Here's a Reddit thread with the question https://www.reddit.com/r/LSD/comments/5aqp8s/lsd_drops_in_ey...
Re:Despite concerns, FDA approves new opioid 10x more powerf... by imsofuture on Friday November 02, 2018 @07:25PM (#18367554)
You can definitely put liquid LSD in your eye.
Re:Despite concerns, FDA approves new opioid 10x more powerf... by Johnny555 on Friday November 02, 2018 @06:14PM (#18367179)
Do they actually dispense drugs in the pure form (i.e. would anyone outside of a pharmacy have access to the drug in a medical setting), or are they diluted in liquid or maybe in a painkilling patch?
Re:Despite concerns, FDA approves new opioid 10x more powerf... by darpa_escapee on Friday November 02, 2018 @07:08PM (#18367463)
To my knowledge, all legal formulations are diluted for administration and only the manufacturer handles the substance in its pure form.

Illicit fentanyl and its derivatives are usually distributed in their pure form, to people who have no training in handling hazardous substances.

Sometimes first responders to fentanyl overdoses will not even be able to enter the room of the victim without hazmat suits, because accidentally breathing in fentanyl dust or touching a surface in which the dust has settled could kill them.

Re:Despite concerns, FDA approves new opioid 10x more powerf... by dogma1138 on Friday November 02, 2018 @04:53PM (#18366642)
It’s the the binding strength which has direct impact on addiction and withdrawal which is a bit scary since Fentanyl is 100 times stronger than morphine already, heroine is only 5 times as strong for comparison.
Re:Despite concerns, FDA approves new opioid 10x more powerf... by skellera on Friday November 02, 2018 @05:15PM (#18366847)
No way that’s true. Buprenorphine has a much higher binding affinity than all the worst opiates yet you don’t see people trying to do that over heroin and all the others.

The strengths you’re speaking of are potency. And even then, most addicts I know would rather have an unlimited supply of oxymorphone than fentanyl or any of the others. At a certain point, cost outweighs all of that.

There’s so much misinformation out there about these drugs.

Re:Despite concerns, FDA approves new opioid 10x more powerf... by dogma1138 on Friday November 02, 2018 @05:32PM (#18366941)
Buprenorphine is a partial agonist of the Mu receptor (the one which causes the most physical dependency) and is antagonist for the rest, it’s also has a very high affinity which displaces other opioids which is why it’s used in addiction treatment.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2581407/

Yes is more to this than just affinity the type and level of the binding to each receptor is also important but on the grand scheme of things in this context it’s not because all the opioids which are primarily used for pain relief are full Mu receptor agonists which is when the simple affinity strength estimate is pretty much sufficient to estimate potency and potential harm.

Also last time I checked the potency is derived directly from the Ki value of the Mu receptor which represents the affinity (regardless of agonism) of the opioid, so these are essentially interchangeable.

Re:Despite concerns, FDA approves new opioid 10x more powerf... by pimeys on Friday November 02, 2018 @05:19PM (#18366867)
You should watch a movie called Reindeerspotting about junkies in Lapland doing buprenorphine. It is quite addictive.
Re:Despite concerns, FDA approves new opioid 10x more powerf... by jessriedel on Friday November 02, 2018 @04:55PM (#18366662)
Are you talking about binding affinity? Do you have a cite for the relationship between this and the relative addictiveness of opioids given at their normal effective doses?

Everything I'm turning up suggests that, in the clinical setting, the "strength of opioids" is a statement about the relative size of the effective dose (in mg). Presumably that's correlated with molecular properties like the affinity, but I don't think that's what the article is talking about.

Re:Despite concerns, FDA approves new opioid 10x more powerf... by dogma1138 on Friday November 02, 2018 @04:57PM (#18366681)
Googling comes up with a WaPo article which seems to cover it pretty well: https://www.washingtonpost.com/graphics/2017/health/opioids-...

Edit: Since you edited your question I think you might want to look at opioid agonism across the range of receptors you should probably be able to find quite few NIH studies.

Re:Despite concerns, FDA approves new opioid 10x more powerf... by jessriedel on Friday November 02, 2018 @05:12PM (#18366812)
I don't think that article answers my question. This seems to be the entire contents that might directly address the issue:

> The new, deadlier drugs are altered opioids that bind in more powerful ways to the brain’s receptors and get to the brain more quickly. The combination of factors can make them thousands of times more deadly.

> All opioids connect to particular brain and nervous system receptors that exist for the body’s natural painkiller, endorphins...

That is the only mention of the word "bind" and the article doesn't contain the word "affinity". It doesn't discuss the relationship between effective-dose-size and potential for addiction, except in cases where it seems to go in the opposite direction of what you suggested:

> Methadone is about three times stronger than morphine, but it does not produce a strong euphoric effect. It also lasts much longer and can address physical dependence on other opioids, making it the most common choice for treating opioid addiction.

Re:Despite concerns, FDA approves new opioid 10x more powerf... by dogma1138 on Friday November 02, 2018 @05:20PM (#18366879)
It did when you only had “do you have a cite for this” check my edit look at opioid agonism studies especially around addiction treatments where weak/partial agonists opioids are used to ease widthrawal symptoms without prolonging addiction.

Which of receptors the opioids can bind to and at what level also has impact on their addiction as many of these receptors regulate different functions iirc the ones that cause the most physical dependence are the strong Mu receptor agonists.

Re:Despite concerns, FDA approves new opioid 10x more powerf... by jessriedel on Friday November 02, 2018 @05:38PM (#18366982)
> It did when you only had “do you have a cite for this” check my edit

Oh gotcha, sorry about that. I edited my top-level comment fast, so I just assumed you hadn't had time to read the initial version.

> opioid agonism studies especially around addiction treatments where weak/partial agonists opioids are used to ease widthrawal symptoms without prolonging addiction.

OK, I spend 10 minutes Googling. I found a few authoritative lists of addictiveness that didn't seem to correlate with effective dose (which I am pretty confident is the measure of "power" being discussed in the article). And I couldn't find anything that asserted a reasonably robust correlation between effective dose size and addictiveness, whether mediated by agonism strength or otherwise. But I understand if you don't want to spend a bunch of time on this. Thanks.

Re:Despite concerns, FDA approves new opioid 10x more powerf... by dogma1138 on Friday November 02, 2018 @05:56PM (#18367086)
Now I understand what are you looking for no at the “effective” dose it likely won’t matter the problem is that effective dose is irrelevant in this case because we are talking about substance abuse.

All full Mu receptors agonists can cause severe physical dependency, the stronger the affinity the more they also can push out other opioids and natural occurring ones and as over time the opioids can actually affect the “shape” of the receptor this is essentially what causes the addiction since what your body produces like endorphine is no longer good enough for you.

So if this will be prescribed like fentanyl and other opioids this will be a problem the opioid epidemic didn’t happen because opioids were tightly prescribed and administered in controlled conditions it happened because you sprained your back and instead of some physiotherapy and a sauna you’ve been given a bottle of pills to chew on like candy.

Re:Despite concerns, FDA approves new opioid 10x more powerf... by jessriedel on Friday November 02, 2018 @06:25PM (#18367238)
Cool, thanks!
Re:Despite concerns, FDA approves new opioid 10x more powerf... by sndean on Friday November 02, 2018 @05:11PM (#18366807)
Not a primary source, but see slide 11 [0]. In this case, for the "10X" I think they're looking at the binding affinity to the u-receptor.

Edit: realized that doesn't answer your question about the relationship between binding affinity, relative effective dose in mg/kg, etc. At least when medicinal chemists I work with say "10X stronger" they're referring to the binding affinity. Not sure about what it means in a person.

https://www.ctsi.ucla.edu/education/files/view/training/docs...

Re:Despite concerns, FDA approves new opioid 10x more powerf... by jessriedel on Friday November 02, 2018 @05:41PM (#18367000)
Thanks! Though I'm willing to bet this technical parameter isn't what WaPo means by "powerful" :)
Re:Despite concerns, FDA approves new opioid 10x more powerf... by dogma1138 on Friday November 02, 2018 @06:06PM (#18367140)
I’m pretty sure it does the “potency” is derived by the Ki value of the opioid to the Mu receptor which is the affinity while they aren’t identical (the lower the Ki the higher the potency) they are interchangeable at these levels unless you are looking for much more complex pharmacology where agonism and multiple receptors come into play.

Since pain relief opioids are full Mu receptor agonists the rest doesn’t really matter in the context of these articles this is accurate enough to be technically correct while not being generalized to all opioids such as low Ki opioids which are mixed agonists or antagonists which can be used to treat addiction and even overdose since they bind to they receptors but don't activate them fully or not at all which means that they block other opioids.

Re:Despite concerns, FDA approves new opioid 10x more powerf... by jessriedel on Friday November 02, 2018 @06:37PM (#18367292)
Sorry, I don't understand. Elsewhere you said

> no at the “effective” dose it likely won’t matter the problem is that effective dose is irrelevant in this case because we are talking about substance abuse.

Do you disagree with either of these?

1. In popular news coverage, or doctors talking with lay patients, the term "power" or "strength" of an opioid is shorthand for it's potency on normal (non-addicted) patients. That is, it is inversely related to the number of milligrams that must be administered to get effective pain relief for some fixed reference injury.

2. The potency of a drug is only weakly correlated with its potential for addiction. There are several opioids that are less potent than average but have a higher propensity for addiction than average, and vice versa.

Re:Despite concerns, FDA approves new opioid 10x more powerf... by dogma1138 on Friday November 02, 2018 @10:23PM (#18368312)
Ok "affinity" it's how strongly it would bind to a receptor.

Then there is agonism or antagonism which can be partial or full.

Full agonism is the "strongest" activation that doesn't have anything to do with affinity because it just means it fully activates the receptor, the affinity is how likely it will be bound to the receptors.

For opioids that are full agonists potency and affinity can be used essentially interchangeably these are all primary pain relief opioids and fully bind to the receptors in the same manner essentially, opioids which are mixed agonists or even antagonists such as those used to treat addiction or withdrawal can have very high affinity but low potency because while they bind to the receptor very strongly they don't fully activate it or even deactivate it but as their affinity is high they can beat other opioids to the binding and block the receptors.

As this drug is a replacement for fentanyl it's a full agonist opioid which means that if it's more potent it has to have a lower Ki value which means higher affinity at a matching ratio.

Re:Despite concerns, FDA approves new opioid 10x more powerf... by bsder on Friday November 02, 2018 @05:00PM (#18366713)
Isn't one of the big issues with the opioid addiction the fact that oxycontin was marketed as being able to control pain for 12 hours when in reality it didn't last that long?

So, with oxycontin, you got a big effect at beginning, wearing off too soon, and craving another--all actions which are really good at reinforcing addiction.

If your binding strength is much better, wouldn't you get lower doses (less big effect at start), which are more effective (less craving), further apart in time (actually controlling the pain like it was supposed to). This seems like a huge win.

Re:Despite concerns, FDA approves new opioid 10x more powerf... by dogma1138 on Friday November 02, 2018 @05:06PM (#18366760)
I’m not an expert on opioids but there are other factors when it comes to how long it lasts the binding strength is just one of them, the delivery method is also important so are other factors such as how quickly it can pass the brain blood barrier, which other receptors it can bind too and what is the half life of the drug in vivo.

Fentanyl for example can administrated with a topical patch due to its relative strength to enable longer duration of pain relief, morphine would require an injection to be as effective.

Re:Despite concerns, FDA approves new opioid 10x more powerf... by grawprog on Friday November 02, 2018 @07:09PM (#18367476)
https://en.m.wikipedia.org/wiki/Sufentanil

This is the drug the article is talking about.

>Sufentanil (R30730, brand name Sufenta) is a synthetic opioid analgesic drug approximately 5 to 10 times more potent than its parent drug, fentanyl, and 500 times as potent as morphine. Structurally, sufentanil differs from fentanyl through the addition of a methoxymethyl group on the piperidine ring (which is believed to reduce duration of action[2]), and the replacement of the phenyl ring by thiophene. Sufentanil first was synthesized at Janssen Pharmaceutica in 1974.[3]

>Sufentanil is marketed for use by specialist centers under different trade names, such as Sufenta and Sufentil. Sufentanil with and without lidocaine or mepivacaine is available as a transdermal patch similar to Duragesic in Europe under trade names such as Chronogesic. It is available as a sublingual tablet under the trade name Dsuvia.[4]

>Currently sufentanil is the strongest opioid painkiller available for use in humans. Although stronger narcotic pain medications do exist, all medications stronger than sufentanil are approved for veterinary use only.

Re:Despite concerns, FDA approves new opioid 10x more powerf... by rscho on Friday November 02, 2018 @05:52PM (#18367064)
Indeed it is potency. In iv form, sufentanyl is usually prescribed at 1/10th the dose of fentanyl, aiming at an equivalent effect.
Re:Despite concerns, FDA approves new opioid 10x more powerf... by new12345 on Friday November 02, 2018 @05:07PM (#18366762)
Power of drug could be quantified based on its impact strength on targeted body functions and side affects on non-targeted ones.
Re:Despite concerns, FDA approves new opioid 10x more powerf... by teilo on Friday November 02, 2018 @04:52PM (#18366633)
It likely means a much more profitable product, since they can get the same effect in 1/10th the dose.
Re:Despite concerns, FDA approves new opioid 10x more powerf... by dogma1138 on Friday November 02, 2018 @04:54PM (#18366655)
Opioids are measured in binding strength (and so pain relief) with morphine as the baseline which ranges from x0.5-x1 for light opioids like Codine to x100 for Fentanyl.

Non opioid pain killers like ibuprofen are usually 1/200-1/300th of morphine.

Re:Despite concerns, FDA approves new opioid 10x more powerf... by PhasmaFelis on Friday November 02, 2018 @05:12PM (#18366816)
Synthesizing the active ingredient is generally very cheap regardless. Research and testing are the big costs in drug development.
Re:Despite concerns, FDA approves new opioid 10x more powerf... by acct1771 on Saturday November 03, 2018 @09:52AM (#18370153)
On paper, at least.

Marketing's probably up there.

Re:Despite concerns, FDA approves new opioid 10x more powerf... by koolba on Friday November 02, 2018 @04:52PM (#18366636)
Is making the physical product a substantial cost of any non generic medication?